CeNeS Pharmaceutical Licenses Exclusive Japanese Rights for CNS7056 to Ono (Japan)
This article was originally published in PharmAsia News
Executive Summary
Biopharmaceutical company CeNeS Pharmaceuticals PLC has licensed the exclusive Japanese rights to its general anaesthetic and short-acting sedative, CNS-7056, to Ono Pharmaceutical Co Ltd. Cenes says it will receive upfront and milestone payments, as well as royalties on Ono's sales of CNS-7056. The company plans to start a phase I study in the US in the first half of 2008 and Ono will start a phase I study in Japan as early as the second half of 2008. (Click here for more